Search research articles
Contact Us
Filters
Showing results (61-70 of 81) with videos related to
Page
of 9
Sort By:
Chemical Science
|
June 7, 2021
Unequivocal structure confirmation of a breitfussin analog by anisotropic NMR measurements
Ikenna E Ndukwe, Yu-Hong Lam, Sunil K Pandey, et al.
Bioorganic & Medicinal Chemistry Letters
|
August 10, 2016
Systematic chemical modifications of single stranded siRNAs significantly improved CTNNB1 mRNA silencing
Wonsuk Chang, Yi Pei, Erin N Guidry, et al.
The Journal of Organic Chemistry
|
August 5, 2017
Asymmetric Formal Synthesis of the Long-Acting DPP-4 Inhibitor Omarigliptin
Feng Peng, Yonggang Chen, Cheng-Yi Chen, et al.
Science (New York, N.Y.)
|
April 29, 2017
A multifunctional catalyst that stereoselectively assembles prodrugs
Daniel A DiRocco, Yining Ji, Edward C Sherer, et al.
Chemical Science
|
May 30, 2017
A rational pre-catalyst design for bis-phosphine mono-oxide palladium catalyzed reactions
Yining Ji, Hongming Li, Alan M Hyde, et al.
Journal of Medicinal Chemistry
|
July 19, 2022
Discovery and Structure-Based Design of Macrocyclic Peptides Targeting STUB1
Simon Ng, Alexander C Brueckner, Soheila Bahmanjah, et al.
Journal of Natural Products
|
November 5, 2020
Denigrins and Dactylpyrroles, Arylpyrrole Alkaloids from a <i>Dactylia</i> sp. Marine Sponge
Unwoo Kang, Laura K Cartner, Dongdong Wang, et al.
Bioorganic & Medicinal Chemistry Letters
|
June 1, 2016
Discovery and development of benzo-[1,2,4]-triazolo-[1,4]-oxazepine GPR142 agonists for the treatment of diabetes
Jonathan E Wilson, Ravi Kurukulasuriya, Christopher Sinz, et al.
Bioorganic & Medicinal Chemistry Letters
|
July 23, 2015
Discovery of substituted (4-phenyl-1H-imidazol-2-yl)methanamine as potent somatostatin receptor 3 agonists
Zhong Lai, Shuwen He, Edward C Sherer, et al.
Journal of Medicinal Chemistry
|
February 13, 2016
Definitive Metabolite Identification Coupled with Automated Ligand Identification System (ALIS) Technology: A Novel Approach to Uncover Structure-Activity Relationships and Guide Drug Design in a Factor IXa Inhibitor Program
Ting Zhang, Yong Liu, Xianshu Yang, et al.
Page
of 9
Search research articles
Search
Showing results (61-70 of 81) with videos related to
Sort By:
Page
of 9
Chemical Science
|
June 7, 2021
Unequivocal structure confirmation of a breitfussin analog by anisotropic NMR measurements
Ikenna E Ndukwe, Yu-Hong Lam, Sunil K Pandey, et al.
Bioorganic & Medicinal Chemistry Letters
|
August 10, 2016
Systematic chemical modifications of single stranded siRNAs significantly improved CTNNB1 mRNA silencing
Wonsuk Chang, Yi Pei, Erin N Guidry, et al.
The Journal of Organic Chemistry
|
August 5, 2017
Asymmetric Formal Synthesis of the Long-Acting DPP-4 Inhibitor Omarigliptin
Feng Peng, Yonggang Chen, Cheng-Yi Chen, et al.
Science (New York, N.Y.)
|
April 29, 2017
A multifunctional catalyst that stereoselectively assembles prodrugs
Daniel A DiRocco, Yining Ji, Edward C Sherer, et al.
Chemical Science
|
May 30, 2017
A rational pre-catalyst design for bis-phosphine mono-oxide palladium catalyzed reactions
Yining Ji, Hongming Li, Alan M Hyde, et al.
Journal of Medicinal Chemistry
|
July 19, 2022
Discovery and Structure-Based Design of Macrocyclic Peptides Targeting STUB1
Simon Ng, Alexander C Brueckner, Soheila Bahmanjah, et al.
Journal of Natural Products
|
November 5, 2020
Denigrins and Dactylpyrroles, Arylpyrrole Alkaloids from a <i>Dactylia</i> sp. Marine Sponge
Unwoo Kang, Laura K Cartner, Dongdong Wang, et al.
Bioorganic & Medicinal Chemistry Letters
|
June 1, 2016
Discovery and development of benzo-[1,2,4]-triazolo-[1,4]-oxazepine GPR142 agonists for the treatment of diabetes
Jonathan E Wilson, Ravi Kurukulasuriya, Christopher Sinz, et al.
Bioorganic & Medicinal Chemistry Letters
|
July 23, 2015
Discovery of substituted (4-phenyl-1H-imidazol-2-yl)methanamine as potent somatostatin receptor 3 agonists
Zhong Lai, Shuwen He, Edward C Sherer, et al.
Journal of Medicinal Chemistry
|
February 13, 2016
Definitive Metabolite Identification Coupled with Automated Ligand Identification System (ALIS) Technology: A Novel Approach to Uncover Structure-Activity Relationships and Guide Drug Design in a Factor IXa Inhibitor Program
Ting Zhang, Yong Liu, Xianshu Yang, et al.
Page
of 9